Nitric oxide therapy is an effective, FDA-approved method to treat conditions like hypoxic respiratory failure with pulmonary hypertension in newborns ages 34 weeks and older. Share on Pinterest Jill ...
Prenatal exposure to air pollution increases the risk of severe respiratory distress in newborn babies, according to new research. The risk increases with exposure specifically to fine particulate ...